Company Filing History:
Years Active: 2004
Title: Wolfgang Hummel: Innovator in Pharmaceutical Preparations
Introduction
Wolfgang Hummel is a notable inventor based in Neuenmarkt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for side effects associated with GnRHa therapy. His innovative work has led to the creation of effective pharmaceutical preparations that address various side effects experienced by patients undergoing this therapy.
Latest Patents
Wolfgang Hummel holds 1 patent for his invention titled "Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy." This patent focuses on pharmaceutical preparations that contain effective amounts of chemically modified derivatives of 17α-estradiol, 17β-estradiol, and estriol. These preparations are designed to alleviate side effects such as hot flashes, prostate enlargement, and gynecomastia that may occur during or after treatment with gonadotropin-releasing hormone analogs or antagonists. Notably, preparations containing 14α, 15α-methylene-1,3,5(10),8-tetraene-3,17α-diol are particularly preferred.
Career Highlights
Wolfgang Hummel is associated with Jenapharm GmbH & Co. KG, where he has been instrumental in advancing pharmaceutical research and development. His expertise in the field has contributed to the company's reputation for innovation and quality in pharmaceutical products.
Collaborations
Wolfgang has collaborated with esteemed colleagues such as Michael Oettel and Ludwig Wildt. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the pharmaceutical industry.
Conclusion
Wolfgang Hummel's contributions to pharmaceutical preparations demonstrate his commitment to improving patient care through innovative solutions. His work continues to influence the field and offers hope for those affected by the side effects of GnRHa therapy.